Integral Diagnostics | IDX - Kewajiban Lancar

Keuangan

AUD

AUD 744.28M

AUD 17.99M

Biaya Penjualan

AUD 11.53M

AUD 74.82M

Kewajiban Lancar

AUD 85.68M

AUD 357.8M

Dividen - Hasil

3.26

AUD 25M

AUD 46.27M

Eps Laba Per Saham

AUD 0.04

Modal Dan Cadangan

AUD 301.71M

Laba Kotor Pada Penjualan

AUD 226.91M

Beban Bunga Utang

AUD 5.34M

Pendapatan Bunga

AUD 482K

AUD 341.63M

Kapitalisasi Pasar

AUD 473.85M

Batas Pemasukan

AUD 6.06M

Biaya Operasional

AUD 219.16M

Laba Operasional

AUD 19.28M

Modal Saham Biasa

AUD 335.09M

Pe Harga Untuk Laba

17.94

Laba Sebelum Pajak

AUD 14.49M

Pendapatan Penjualan

AUD 238.44M

Beban Penjualan Dan Administrasi

AUD 169.98M

AUD 1.85M

Kreditur Perdagangan

AUD 28.28M

Debitur Perdagangan

AUD 24.82M

	Kewajiban Lancar	Perubahan		Tanggal
Alcidion	AUD 22.33M		1.47M	2025-12
Ansell	USD 468.9M		53.1M	2025-12
Cochlear	AUD 558.9M		43.4M	2025-12
CSL	USD 4.61B		207M	2025-12
Healius	AUD 804.2M		203.9M	2024-12
Mayne Pharma	AUD 313.94M		18.28M	2024-06
Monash IVF	AUD 53.85M		7.56M	2025-12
Nanosonics	AUD 36.59M		3.2M	2025-12
Polynovo	AUD 22.81M		5.07M	2025-12
Ramsay Health Care	AUD 3.95B		514.2M	2025-12
ResMed	USD 1.25B		7.39M	2025-12
Sigma Healthcare	AUD 1.7B		1.33B	2025-12
Sonic Healthcare	AUD 2.23B		92.84M	2024-12
Telix Pharmaceuticals	AUD 231.62M		66.96M	2025-12